NEOGENOMICS INC·4

Apr 4, 5:04 PM ET

Kulkarni Shashikant 4

4 · NEOGENOMICS INC · Filed Apr 4, 2023

Insider Transaction Report

Form 4
Period: 2023-04-01
Kulkarni Shashikant
President of Lab Operations
Transactions
  • Tax Payment

    Common Stock

    2023-04-013,75982,673 total
Holdings
  • Stock Option (Right to Buy)

    Exercise: $12.15Exp: 2029-04-01Common Stock (132,744 underlying)
    132,744
  • Stock Option (Right to Buy)

    Exercise: $10.12Exp: 2029-08-01Common Stock (51,653 underlying)
    51,653
Footnotes (3)
  • [F1]Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the April 1, 2023 vesting of restricted stock.
  • [F2]On April 1, 2022, Dr. Kulkarni was granted 132,744 stock options. These options vest ratably over the first four anniversary dates of the grant date.
  • [F3]On August 1, 2022, Dr. Kulkarni was granted 51,653 stock options. These options vest ratably over the first four anniversary dates of the grant date.

Documents

1 file
  • 4
    wf-form4_168064226383246.xmlPrimary

    FORM 4